Adaptive TCR (Seattle, WA) a commercial-stage provider of online solutions for large scale immune system profiling, closed a $5.8M Series B financing, bringing the total round to $10.3M. Participants were not identified.

The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science professionals on-line and in-print. Contact for details.